全文获取类型
收费全文 | 1419篇 |
免费 | 70篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 75篇 |
妇产科学 | 13篇 |
基础医学 | 151篇 |
口腔科学 | 43篇 |
临床医学 | 131篇 |
内科学 | 256篇 |
皮肤病学 | 63篇 |
神经病学 | 113篇 |
特种医学 | 265篇 |
外国民族医学 | 1篇 |
外科学 | 142篇 |
综合类 | 29篇 |
预防医学 | 99篇 |
眼科学 | 23篇 |
药学 | 57篇 |
中国医学 | 1篇 |
肿瘤学 | 57篇 |
出版年
2021年 | 15篇 |
2019年 | 15篇 |
2018年 | 25篇 |
2017年 | 21篇 |
2016年 | 16篇 |
2015年 | 27篇 |
2014年 | 35篇 |
2013年 | 37篇 |
2012年 | 38篇 |
2011年 | 29篇 |
2010年 | 62篇 |
2009年 | 53篇 |
2008年 | 34篇 |
2007年 | 42篇 |
2006年 | 41篇 |
2005年 | 52篇 |
2004年 | 21篇 |
2003年 | 23篇 |
2002年 | 28篇 |
2001年 | 31篇 |
2000年 | 26篇 |
1999年 | 34篇 |
1998年 | 55篇 |
1997年 | 53篇 |
1996年 | 51篇 |
1995年 | 38篇 |
1994年 | 43篇 |
1993年 | 38篇 |
1992年 | 28篇 |
1991年 | 31篇 |
1990年 | 20篇 |
1989年 | 41篇 |
1988年 | 55篇 |
1987年 | 32篇 |
1986年 | 33篇 |
1985年 | 48篇 |
1984年 | 17篇 |
1983年 | 13篇 |
1982年 | 17篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 12篇 |
1978年 | 20篇 |
1977年 | 9篇 |
1976年 | 22篇 |
1974年 | 12篇 |
1971年 | 11篇 |
1969年 | 11篇 |
1967年 | 8篇 |
1965年 | 8篇 |
排序方式: 共有1524条查询结果,搜索用时 15 毫秒
1.
2.
Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. 总被引:5,自引:0,他引:5
William D Leslie Colleen Metge Elizabeth A Salamon C Kin Yuen 《Journal of clinical densitometry》2002,5(2):117-130
The ease of measurement and the quantitative nature of bone mineral densitometry (BMD) is clinically appealing. Despite BMD's proven capability to stratify fracture risk, data indicate that clinical risk factors provide complementary information on fracture susceptibility that is independent of BMD. Methods to quantify fracture risk using both clinical and BMD variables would have great appeal for clinical decision-making. We describe a procedure for quantifying hip fracture risk (5-yr and remaining lifetime) based on (1) the individual's age alone (base model, assuming average clinical risk factors and bone density), (2) incorporation of multiple patient-specific clinical risk factor data in the base model, and (3) incorporation of both patient-specific clinical risk factor data and BMD results. 相似文献
3.
M Ardigo I Malizewsky ML Dell'Anna E Berardesca M Picardo 《Journal of the European Academy of Dermatology and Venereology》2007,21(10):1344-1350
BACKGROUND: Vitiligo is the most common pigmentary disorder with a global incidence from 0.1% to 2% in different geographical areas. Histopathology and histochemistry have shown the reduction of melanocytes in achromic patches, but microscopic changes of lesional and non-lesional skin are still not completely understood. Reflectance confocal microscopy (RCM), based on the different light reflectance index of cutaneous structures, allowed in vivo, en face microscopic evaluation of superficial skin layers with a resolution similar to skin histology. AIM: The purpose of this study was to evaluate RCM features of lesional and non-lesional skin of vitiligo patients. Moreover, re-pigmented areas were taken into consideration in order to evaluate melanocyte response to ultraviolet B (UVB) radiation. SUBJECTS AND METHODS: Sixteen patients of different phototypes affected by active non-segmental vitiligo and 10 controls were enrolled in the study. In vivo skin imaging was done using a commercially available RCM (Lucid, Vivascope 1500. Re-pigmented areas from 6 to 16 patients (after UVB narrow-band therapy) were also examined. RESULTS: Vitiligo lesions showed the disappearance of the bright rings normally seen at the dermo-epidermal junction. Moreover, non-lesional skin of vitiligo patients showed unexpected changes as the presence of half-rings or scalloped border-like features of the bright papillary rings. In re-pigmented areas after UVB narrow band therapy, the presence of activated, dendritic melanocytes was seen. CONCLUSIONS: Considering our results, and following further studies, RCM clinical applications could be used in the therapeutic monitoring and evaluation of the evolution of vitiligo. 相似文献
4.
5.
6.
7.
8.
Patients with non-insulin-dependent diabetes mellitus (NIDDM) who have chronic hyperglycemia lose acute incremental insulin responses to glucose but are able to briskly respond to other beta-cell secretagogues. To investigate whether this is a defect specific for glucose or represents a more general phenomenon, we measured the insulin responses to acute intravenous tolbutamide in 10 obese patients with NIDDM both before and during sulfonylurea therapy with tolazamide. Comparable glycemia was achieved with oral dextrose 2 h before intravenous testing. To assess beta-cell responsiveness to a nonsulfonylurea secretagogue, 1 mg glucagon was administered intravenously during tolazamide therapy. In seven patients, the mean peak insulin increment 5 or 10 min after intravenous tolbutamide was 54 +/- 11 microU/ml when not receiving tolazamide (0.14 +/- 1.3 microU/ml) with tolazamide (P less than .001), even though serum insulin responded rapidly to intravenous glucagon. In four patients tested for reversibility of their refractoriness to intravenous tolbutamide during chronic tolazamide therapy, the mean peak insulin increment 1 wk after discontinuing tolazamide was 79 +/- 22 microU/ml. A relatively rapid development of refractoriness was documented in four patients who were tested only 12 h after beginning tolazamide therapy; the mean peak insulin increments 5-10 min after intravenous tolbutamide were undetectable (-0.5 microU/ml), yet responses to intravenous glucagon were evident. In these NIDDM patients, exposure of pancreatic beta-cells to sustained levels of sulfonylureas induces a reversible state of refractoriness to acute stimulation with sufonylureas but not to another secretagogue.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
9.
10.
Kinnison ML; Perler BA; Kaufman SL; Mitchell SE; Kadir S; Williams GM; White RI Jr 《Radiology》1986,160(3):727-730
In situ saphenous vein grafts are being used with increasing frequency for bypass procedures involving the femoral and popliteal arteries. Complications of these procedures include anastomotic stenoses and persistent arteriovenous fistulae that may result in failure of the graft. Balloon angioplasty and embolotherapy with detachable balloons were employed successfully in three or four recent cases of patients with complications from in situ grafts. Tailored angiography is essential for evaluating in situ grafts, and interventional techniques are extremely useful for managing complications. 相似文献